뇌 이미징 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Brain Imaging Devices Market Size, Share & Trends Analysis Report By Product (Devices (EEG, MRI)), By Application (Epilepsy, Brain Tumor), By Modality (Fixed, Portable), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

뇌 이미징 디바이스 시장의 성장과 동향 :

세계의 뇌 이미징 디바이스 시장 규모는 2024-2030년 CAGR 8.14%로 성장하며, 2030년에는 90억 4,000만 달러에 달할 것으로 예측됩니다.

시장 성장을 가속하는 주요 요인으로는 기술 발전, 연구개발 활동 증가, 뇌 및 신경 질환의 유병률 증가 등을 들 수 있습니다. 예를 들어 국제암연구소는 2022년 전 세계에서 약 32만 1,731건의 뇌 및 중추신경계 암이 발생했다고 보고했습니다. 이 유형의 암은 다른 모든 유형의 암 중에서 19위를 차지할 것으로 지적되고 있습니다.

기술 발전은 시장 성장에 기여하는 주요 요인 중 하나가 될 것으로 예상됩니다. 이러한 발전은 이미지 해상도 향상, 데이터 처리 능력 향상, 새로운 영상 양식 개발 등 다양한 혁신을 포함하고 있습니다. 이러한 발전은 뇌 영상의 정확성과 효율성을 향상시킬 뿐만 아니라 신경과학, 신경학, 정신의학, 신경외과 등 다양한 분야로의 적용을 확대할 것입니다. 예를 들어 Philips는 2024년 2월 자기공명영상(MRI) 소프트웨어 솔루션 전문 기업 Synthetic MR과 제휴하여 다발성 경화증(MS), 외상성 뇌손상(TBI), 치매 등 뇌 질환의 진단 및 치료 효과 평가에 객관적인 의사결정 지원을 제공하는 주목할 만한 Smart Quant Neuro 3D 기술은 다양한 뇌 조직의 자동 측정을 제공하여 뇌 질환에 대한 의사결정을 지원하는 스마트 퀀트 뉴로 3D 기술을 발표했습니다.

질병의 진행을 모니터링하고 치료 결과를 평가합니다.

또한 신경질환의 유병률 증가와 인구 고령화는 첨단 뇌영상 기술에 대한 수요 증가에 기여하고 있습니다. 지속적인 연구개발이 기술 혁신과 시장 확대의 원동력이 되고 있습니다. 또한 시장 진출기업의 다양한 노력은 시장 성장에 더욱 기여할 것으로 예상됩니다. 예를 들어 2022년 11월 Neurosteer는 단일 채널 뇌파(EEG) 뇌 모니터링 플랫폼에 대한 FDA 승인을 획득했습니다. 이 회사는 기존의 EEG 시스템을 혁신적으로 개선하기 위해 접착식 전극 스트립을 통합하고 소형 센서에 원활하게 연결하여 보다 단순하고 사용자 친화적인 솔루션을 제공합니다.

뇌 이미징 디바이스 보고서 - 하이라이트

• 제품별로는 디바이스 부문이 매출 점유율의 80% 이상을 차지하며 시장을 독점하고 있습니다.
• 액세서리 분야는 2024-2030년 가장 빠른 CAGR 9.05%로 성장할 것으로 예상됩니다.
• 용도별로는 뇌종양 분야가 2023년 약 23%로 가장 큰 시장 점유율을 차지했습니다.
• 간질 부문은 예측 기간 중 CAGR 9.29%로 가장 빠르게 성장할 것으로 예상됩니다.
• 양식별로는 고정식 뇌 이미징 디바이스 부문이 2023년 매출 점유율 47.15%를 차지하며 시장을 장악했습니다.
• 휴대용 뇌 이미징 디바이스 부문은 2024-2030년 가장 빠른 CAGR 8.90%로 성장할 것으로 예상됩니다.
• 최종 용도별로는 병원이 2023년 37.73%의 매출 점유율을 차지하며 가장 큰 비중을 차지했습니다.
• 북미는 2023년 39% 이상의 점유율로 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 뇌 이미징 디바이스 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
• 뇌 이미징 디바이스 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 뇌 이미징 디바이스 시장 : 제품 추정·동향 분석

• 부문 대시보드
• 세계의 뇌 이미징 디바이스 시장 : 제품의 변동 분석
• 세계의 뇌 이미징 디바이스 시장 규모와 동향 분석, 제품별, 2018-2030년
• 디바이스
• 액세서리

제5장 뇌 이미징 디바이스 시장 : 용도 추정·동향 분석

• 부문 대시보드
• 세계의 뇌 이미징 디바이스 시장 : 용도의 변동 분석
• 세계의 뇌 이미징 디바이스 시장 규모와 동향 분석, 용도별, 2018-2030년
• 뇌졸중
• 뇌종양
• 외상성 뇌손상(TBI)
• 간질
• 수면무호흡
• 두통
• 구조 이상
• 기타 용도

제6장 뇌 이미징 디바이스 시장 : 모달리티 추정·동향 분석

• 부문 대시보드
• 세계의 뇌 이미징 디바이스 시장 : 모달리티의 변동 분석
• 세계의 뇌 이미징 디바이스 시장 규모와 동향 분석, 모달리티별, 2018-2030년
• 고정
• 휴대용
• 웨어러블

제7장 뇌 이미징 디바이스 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 세계의 뇌 이미징 디바이스 시장 : 최종 용도 변동 분석
• 세계의 뇌 이미징 디바이스 시장 규모와 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 영상 진단 센터
• 외래 수술 센터
• 기타

제8장 뇌 이미징 디바이스 시장 : 제품, 용도, 모달리티, 최종 용도별 지역 추정·동향 분석

• 지역별 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계 지역 시장 스냅숏
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 구도

• 주요 시장 참여 기업별 최근 동향과 영향 분석
• 기업/경쟁의 분류
• 주요 기업의 시장 점유율 분석, 2023년
• 기업 포지션 분석
• 기업 분류(신규 기업, 이노베이터, 리더)
• 기업 개요
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • Medtronic
  • Compumedics Limited
  • MEGIN
  • CTF MEG Neuro Innovations, Inc
  • FieldLine Inc
  • Cerca Magnetics Limited
  • Advanced Brain Monitoring, Inc.
  • Canon Medical Systems Corporation
  • Natus
  • Magstim EGI
  • Cadwell
  • Nihon Kohden Corporation
  • NeuroLogica Corp.

KSA

영문 목차

영문목차

Brain Imaging Devices Market Growth & Trends:

The global brain imaging devices market size is anticipated to reach USD 9.04 billion by 2030, growing at a CAGR of 8.14% from 2024 to 2030. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.

Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases,

monitors disease progression, and assesses therapy results.

Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.

Brain Imaging Devices Report Highlights:

• Based on product, the devices segment dominated the market by capturing over 80% of the revenue share
• The accessories segment is anticipated to grow at the fastest CAGR of 9.05% from 2024 to 2030
• Based on application, the brain tumor segment held the largest market share of around 23% in 2023
• The epilepsy segment is expected to grow at the fastest CAGR of 9.29% during the forecast period
• Based on modality, the fixed brain imaging devices segment dominated the market in 2023 by capturing 47.15% of the revenue share
• Portable brain imaging devices segment is expected to grow at the fastest CAGR of 8.90% from 2024 to 2030
• Based on end-use, hospitals held a majority revenue share of 37.73% in 2023
• North America dominated the market with a share of over 39% in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Modality
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. Modality outlook
  • 2.2.4. End-use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Brain Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing incidence of neurological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increase in R&D activities
    • 3.2.1.4. Rising awareness of early disease diagnosis and treatment
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of brain imaging devices
    • 3.2.2.2. Lack of skilled professionals to operate the technologically advanced brain imaging devices
    • 3.2.2.3. Stringent regulatory approvals
• 3.3. Brain Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Brain Imaging Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Brain Imaging Devices Product Market Movement Analysis
• 4.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Devices
  • 4.4.1. Devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. EEG
    • 4.4.2.1. EEG market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. MEG
    • 4.4.3.1. MEG market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. MRI
    • 4.4.4.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. CT
    • 4.4.5.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. PET
    • 4.4.6.1. PET market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Other Devices
    • 4.4.7.1. Other devices market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Accessories
  • 4.5.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Electrodes
    • 4.5.2.1. Electrodes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Sensors
    • 4.5.3.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other Accessories
    • 4.5.4.1. Other accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Brain Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Brain Imaging Devices Application Market Movement Analysis
• 5.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Stroke
  • 5.4.1. Stroke market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Brain Tumor
  • 5.5.1. Brain tumor market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Traumatic brain injury (TBI)
  • 5.6.1. Traumatic brain injury (TBI) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Epilepsy
  • 5.7.1. Epilepsy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Sleep Apnea
  • 5.8.1. Sleep apnea market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Headache
  • 5.9.1. Headache market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Structural anomalies
  • 5.10.1. Structural anomalies market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Other Applications
  • 5.11.1. Other applications market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Brain Imaging Devices Market: Modality Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Brain Imaging Devices Modality Market Movement Analysis
• 6.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 6.4. Fixed
  • 6.4.1. Fixed market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Portable
  • 6.5.1. Portable market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Wearable
  • 6.6.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Brain Imaging Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Brain Imaging Devices End Use Market Movement Analysis
• 7.3. Global Brain Imaging Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Brain Imaging Devices Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End-use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2023
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. GE HealthCare
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Siemens Healthineers AG
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Koninklijke Philips N.V.
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Medtronic
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Compumedics Limited
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. MEGIN
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. CTF MEG Neuro Innovations, Inc
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. FieldLine Inc
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Cerca Magnetics Limited
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Advanced Brain Monitoring, Inc.
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Product benchmarking
    • 9.6.10.4. Strategic initiatives
  • 9.6.11. Canon Medical Systems Corporation
    • 9.6.11.1. Company overview
    • 9.6.11.2. Financial performance
    • 9.6.11.3. Product benchmarking
    • 9.6.11.4. Strategic initiatives
  • 9.6.12. Natus
    • 9.6.12.1. Company overview
    • 9.6.12.2. Financial performance
    • 9.6.12.3. Product benchmarking
    • 9.6.12.4. Strategic initiatives
  • 9.6.13. Magstim EGI
    • 9.6.13.1. Company overview
    • 9.6.13.2. Financial performance
    • 9.6.13.3. Product benchmarking
    • 9.6.13.4. Strategic initiatives
  • 9.6.14. Cadwell
    • 9.6.14.1. Company overview
    • 9.6.14.2. Financial performance
    • 9.6.14.3. Product benchmarking
    • 9.6.14.4. Strategic initiatives
  • 9.6.15. Nihon Kohden Corporation
    • 9.6.15.1. Company overview
    • 9.6.15.2. Financial performance
    • 9.6.15.3. Product benchmarking
    • 9.6.15.4. Strategic initiatives
  • 9.6.16. NeuroLogica Corp.
    • 9.6.16.1. Company overview
    • 9.6.16.2. Financial performance
    • 9.6.16.3. Product benchmarking
    • 9.6.16.4. Strategic initiatives

관련자료